We are live on
!
Find out more
RCA
Resonant Capital Advisors Portfolio holdings
AUM
$2.09B
1-Year Est. Return
20.07%
This Fund
S&P 500
This Quarter
Est. Return
+7.52%
1 Year Est. Return
+20.07%
3 Year Est. Return
+50.65%
5 Year Est. Return
+54.9%
10 Year Est. Return
–
AUM
$665M
AUM Growth
+$90M
(+16%)
Cap. Flow
+$49.9M
Cap. Flow
% of AUM
7.5%
Top 10 Holdings %
Top 10 Hldgs %
42.64%
Holding
213
New
23
Increased
145
Reduced
18
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marqeta
MQ
|
+$4.47M |
| 2 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$3.04M |
| 3 |
iShares National Muni Bond ETF
MUB
|
+$2.42M |
| 4 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$2.28M |
| 5 |
Vanguard Dividend Appreciation ETF
VIG
|
+$2.26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$2.87M |
| 2 |
Biogen
BIIB
|
+$995K |
| 3 |
CTXS
Citrix Systems Inc
CTXS
|
+$505K |
| 4 |
Exelixis
EXEL
|
+$280K |
| 5 |
iShares Floating Rate Bond ETF
FLOT
|
+$231K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.19% |
| 2 | Healthcare | 5.93% |
| 3 | Financials | 5.41% |
| 4 | Consumer Discretionary | 3.64% |
| 5 | Consumer Staples | 2.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVO
201
Novo Nordisk
NVO
$197B
| $205K | 0.03% |
+3,664
| New | +$198K |
|
202
Infosys
INFY
$50.5B
| $202K | 0.03% |
+8,000
| New | +$186K |
|
|
WCN
203
Waste Connections
WCN
$41.5B
| $200K | 0.03% |
+1,467
| New | +$195K |
|
204
Ericsson
ERIC
$33B
| $110K | 0.02% |
10,081
| – | – |
|
|
205
Biogen
BIIB
$30.5B
| – | – |
-3,515
| Closed | -$995K |
|
206
Citigroup
C
$231B
| – | – |
-2,974
| Closed | -$209K |
|
|
207
Exelixis
EXEL
$14.3B
| – | – |
-13,229
| Closed | -$280K |
|
|
208
iShares Floating Rate Bond ETF
FLOT
$10.3B
| – | – |
-4,550
| Closed | -$231K |
|
|
IBDQ
209
DELISTED
iShares iBonds Dec 2025 Term Corporate ETF
IBDQ
| – | – |
-8,086
| Closed | -$217K |
|
210
Medtronic
MDT
$110B
| – | – |
-1,751
| Closed | -$221K |
|
|
IBDP
211
DELISTED
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
| – | – |
-8,292
| Closed | -$218K |
|
|
CTXS
212
DELISTED
Citrix Systems Inc
CTXS
| – | – |
-4,705
| Closed | -$505K |
|
|
IBDM
213
DELISTED
iShares iBonds Dec 2021 Term Corporate ETF
IBDM
| – | – |
-8,749
| Closed | -$216K |
|
Similar funds
ACM
IHAM
CL
NSCM
ACG
NSUP
SFS
BWC
Resonant Capital Advisors's Q4 2021 Portfolio in Review
As of Q4 2021, Resonant Capital Advisors held 213 positions worth $665M, up 16% from $575M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Resonant Capital Advisors deployed $49.9M of net new capital in Q4 2021, opening 23 new positions and adding to 145 existing holdings. Its largest new stake was Marqeta: 50,000 shares worth $3.43M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Xilinx Inc, an estimated $2.87M trimmed.
- Resonant Capital Advisors's largest Q4 2021 buy was Marqeta: 50,000 shares worth $3.43M.
- Resonant Capital Advisors added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2021, an estimated $3.04M increase.
- Resonant Capital Advisors's biggest Q4 2021 reduction was Xilinx Inc, cutting an estimated $2.87M.
- Resonant Capital Advisors fully exited Biogen in Q4 2021, selling an estimated $995K.
- Resonant Capital Advisors's ten largest holdings make up 43% of its $665M portfolio in Q4 2021.
- Resonant Capital Advisors opened 23 new positions and closed 9 in Q4 2021.
- Resonant Capital Advisors's portfolio value rose 16% quarter-over-quarter to $665M.
Based on Resonant Capital Advisors's 13F filing for Q4 2021, filed 26 Jan 2022.